Toronto, Ontario--(Newsfile Corp. - January 7, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce the launch of its MOD and .decimal product portfolio on the Mendo Medical Cannabis platform ("Mendo"), representing Glow's first formal entry into the Canadian medical cannabis channel and extending access to its products for registered medical patients nationwide.
This launch represents an important milestone in Glow's commercial strategy, making its full portfolio (14 SKUs) of next-generation cannabis products available to medical patients across Canada, including veterans, who value greater consistency, dose-control, and personalization.
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/3920/279660_e5d8076154dd48a0_001full.jpg
Mendo Medical Cannabis is one of Canada's leading medical cannabis providers, serving registered patients across Canada, with a long-standing focus on veterans through dedicated support programs. Based in Quebec, Mendo operates a national online sales platform www.mendomedical.ca, providing both civilians and veterans with easy, secure access to high-quality cannabis products from Canada's top licensed producers.
"With this launch on Mendo, Glow is expanding into an important new channel and makes our innovative products accessible to medical cannabis patients across Canada for the first time," said Rob Carducci, CEO of Glow Lifetech. "Medical Cannabis has historically been the first point of legalization in many global markets, and recent U.S. moves to reclassify cannabis to Schedule III1 underscore the continued relevance of medical-first frameworks. Our core technology is rooted in medical-caliber science, and partnering with leaders like Mendo, who are deeply focused on serving medical patients and veterans, aligns well with our long-term strategy to build scalable, globally relevant product platforms grounded in effectiveness, consistency, and dose-control."
"We are delighted to work with Glow to offer MOD and .decimal products to our members through our national sales portal, accessible by medical patients Canada-wide," said Josee Bissonnette, CEO of Mendo. "Our focus has always been on giving patients access to high-quality, innovative products, and we believe Glow's offerings will resonate well with our patient community."
The addition of the medical channel further diversifies Glow's distribution mix heading into 2026 and reinforces the scalability of its business model. Alongside its growing presence with major provincial retailers, this expansion positions the Company to serve a broader customer base while maintaining focus on operational efficiency and long-term value creation.
SUBSCRIBE: For more information on Glow or to subscribe to the Company's mail list visit: https://www.glowlifetech.com/news
About Mendo Medical
Mendo operates from its advanced facility in St. Jean Sur Richelieu, minutes from downtown Montreal. It offers a comprehensive online portal for medical cannabis patients in Canada, featuring a curated selection of products from top licensed producers. Mendo's mission is to provide reliable, high-quality medical cannabis to patients and veterans, affirming its leadership in the Canadian medical cannabis market.
About Glow Lifetech Corp
Glow Lifetech is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption and effectiveness. Glow has a groundbreaking, plant-based MyCell Technology delivery system, which transforms poorly absorbed natural compounds into enhanced water-compatible concentrates that unlock the full healing potential of the valuable compounds.
Website: www.glowlifetech.com
Contact:
Rob Carducci, CEO
Glow Lifetech Corp.
TF. 855-442-GLOW (4569)
ir@glowlifetech.com
FORWARD-LOOKING STATEMENTS
This press release contains statements which constitute "forward-looking information" within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future activities. Forward-looking information is often identified by the words "may," "would," "could," "should," "will," "intend," "plan," "anticipate," "believe," "estimate," "expect" or similar expressions and include information regarding: (i) statements regarding the future direction of the Company (ii) the ability of the Company to successfully achieve its business and financial objectives, and (iii) expectations for other economic, business, and/or competitive factors. Investors are cautioned that forward-looking information is not based on historical facts but instead reflect the Company's management's expectations, estimates or projections concerning the business of the Company's future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the combined company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: changes in general economic, business and political conditions, including changes in the financial markets; and in particular in the ability of the Company to raise debt and equity capital in the amounts and at the costs that it expects; adverse changes in the public perception of the Company's products; decreases in the prevailing prices for the Company's products; adverse changes in applicable laws; or adverse changes in the application or enforcement of current laws; compliance with extensive government regulation and related costs, and other risks described in the Company's public disclosure documents filed on SEDAR+ at www.sedarplus.ca. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.
No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.
1 https://www.whitehouse.gov/presidential-actions/2025/12/increasing-medical-marijuana-and-cannabidiol-research/
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/279660
Source: Glow Lifetech Corp.
